Detalhe da pesquisa
1.
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells.
Nat Immunol
; 25(1): 88-101, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012415
2.
The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers.
Front Immunol
; 13: 1052090, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36685546
3.
Effects of the Haemodynamic Stimulus on the Location of Carotid Plaques Based on a Patient-Specific Mechanobiological Plaque Atheroma Formation Model.
Front Bioeng Biotechnol
; 9: 690685, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195181
4.
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.
Front Immunol
; 12: 752699, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759930
5.
Characterization and modulation of anti-αßTCR antibodies and their respective binding sites at the ßTCR chain to enrich engineered T cells.
Mol Ther Methods Clin Dev
; 22: 388-400, 2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514030
6.
TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A*24:02 transgenic mice.
J Leukoc Biol
; 107(6): 1069-1079, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022317
7.
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds.
J Immunother Cancer
; 9(11)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815357